EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β

Timo W M De Groof iD, Yoline Lauwers iD, Tessa De Pauw iD, Mohit Saxena, Cécile Vincke iD, Jolien Van Craenenbroeck iD, Catherine Chapon iD, Roger Le Grand, Geert Raes iD, Thibaut Naninck, Jo A Van Ginderachter iD, Nick Devoogdt iD

European Journal of Nuclear Medicine and Molecular Imaging · 2024

DOI: 10.1007/s00259-024-06896-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Timo W M De Groof und 11 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging and Therapy Laboratory, Vrije Universiteit Brussel, Brussels, Belgium. timo.de.groof@vub.be. Hauptthemen laut MEDLINE: Single-Domain Antibodies, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Horizon 2020, Strategic Research Programme, Wetenschappelijk Fonds Willy Gepts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: While immunotherapy has revolutionized the oncology field, variations in therapy responsiveness limit the broad applicability of these therapies. Diagnostic imaging of immune cell, and specifically CD8+ T cell, dynamics could allow early patient stratification and result in improved therapy efficacy and safety. In this study, we report the development of a nanobody-based immunotracer for non-invasive SPECT and PET imaging of human CD8+ T-cell dynamics. METHODS: Nanobodies targeting human CD8β were generated by llama immunizations and subsequent biopanning. The lead anti-human CD8β nanobody was characterized on binding, specificity, stability and toxicity. The lead nanobody was labeled with technetium-99m, gallium-68 and copper-64 for non-invasive imaging of human T-cell lymphomas and CD8+ T cells in human CD8 transgenic mice and non-human primates by SPECT/CT or PET/CT. Repeated imaging of CD8+ T cells in MC38 tumor-bearing mice allowed visualization of CD8+ T-cell dynamics. RESULTS: The nanobody-based immunotracer showed high affinity and specific binding to human CD8 without unwanted immune activation. CD8+ T cells were non-invasively visualized by SPECT and PET imaging in naïve and tumor-bearing mice and in naïve non-human primates with high sensitivity. The nanobody-based immunotracer showed enhanced specificity for CD8+ T cells and/or faster in vivo pharmacokinetics compared to previous human CD8-targeting immunotracers, allowing us to follow human CD8+ T-cell dynamics already at early timepoints. CONCLUSION: This study describes the development of a more specific human CD8+ T-cell-targeting immunotracer, allowing follow-up of immunotherapy responses by non-invasive imaging of human CD8+ T-cell dynamics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesCD8-Positive T-LymphocytesAnimalsHumansMiceCD8 AntigensSingle Photon Emission Computed Tomography Computed TomographyRadioactive TracersCopper Radioisotopes

Stichwörter der Autor:innen

Immuno-imagingNanobodiesNuclear imagingT-cell dynamics

Substanzen

Single-Domain AntibodiesCD8 AntigensRadioactive TracersCopper Radioisotopes

Autor:innen und Institutionen

  • Molecular Imaging and Therapy Laboratory, Vrije Universiteit Brussel, Brussels, Belgium. timo.de.groof@vub.be.
  • Molecular Imaging and Therapy Laboratory, Vrije Universiteit Brussel, Brussels, Belgium.
  • Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Fontenay-aux-Roses & Le Kremlin-Bicêtre, Inserm, Paris, CEA, France.
  • Laboratory of Myeloid Cell Immunology, VIB Center for Inflammation Research, Brussels, Belgium.
  • Brussels Center for Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
  • Molecular Imaging and Therapy Laboratory, Vrije Universiteit Brussel, Brussels, Belgium. nick.devoogdt@vub.be.

ORCID-Profile: Timo W M De Groof, Yoline Lauwers, Tessa De Pauw, Cécile Vincke, Jolien Van Craenenbroeck, Catherine Chapon, Geert Raes, Jo A Van Ginderachter, Nick Devoogdt

Förderung

  • Horizon 2020
  • Strategic Research Programme
  • Wetenschappelijk Fonds Willy Gepts
  • Fonds Wetenschappelijk Onderzoek
  • Agence Nationale de la Recherche

Zitieren

APA

De Groof, T. W. M., Lauwers, Y., De Pauw, T., Saxena, M., Vincke, C., Van Craenenbroeck, J., Chapon, C., Le Grand, R., Raes, G., Naninck, T., Van Ginderachter, J. A., & Devoogdt, N. (2024). Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06896-3

Vancouver

De Groof TWM, Lauwers Y, De Pauw T, Saxena M, Vincke C, Van Craenenbroeck J, et al. Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β. European Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.1007/s00259-024-06896-3

BibTeX
@article{DeGroof2024,
  author = {De Groof, Timo W M and Lauwers, Yoline and De Pauw, Tessa and Saxena, Mohit and Vincke, Cécile and Van Craenenbroeck, Jolien and Chapon, Catherine and Le Grand, Roger and Raes, Geert and Naninck, Thibaut and Van Ginderachter, Jo A and Devoogdt, Nick},
  title = {Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  doi = {10.1007/s00259-024-06896-3}
}
Kostenlos starten →